"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente Santa Clara conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 14 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Santa Clara" #1 sponsor was "Pfizer" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "BioNTech SE" with 3 trials sponsored, "University of California, San Francisco" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Santa Clara" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Kaiser Permanente" with 2 trials as a collaborator, "American Medical Systems" with 1 trials as a collaborator, "Arkansas Children's Hospital Research Institute" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Santa Clara" are "Breast Cancer" (2 trials), "COVID-19" (2 trials), "Ovarian Cancer" (2 trials), "SARS-CoV-2 Infection" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Kaiser Permanente Santa Clara" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Santa Clara" are "Drug" (15 trials), "Biological" (9 trials), "Other" (5 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials), "13vPnC" (2 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Santa Clara" are 21 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente Santa Clara". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Kaiser Permanente Santa Clara, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Santa Clara, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Kaiser Permanente Santa Clara has several departments that took part in Clinical trials: "Kaiser Permanente Medical Center Lab Drawing Station" - 2 trials, "Kaiser Permanente Santa Clara Emergency Department" - 2 trials